CN108976218A
|
|
Posaconazole succinyl adduct impurity and its preparation method and application
|
CN106699741A
|
|
New crystal form of benzyl ether posaconazole, and preparation method and use thereof
|
CN105315231A
|
|
Preparation method of linezolid related substance
|
CN104774134A
|
|
Synthetic method of cinacalcet hydrochloride and intermediate compound of cinacalcet hydrochloride
|
CN103483333A
|
|
Crystal form of penehyclidine hydrochloride racemic mixture I and preparation method thereof
|
CN103239724A
|
|
Anti-thrombosis combined drug and pharmaceutical composition thereof
|
CN103271872A
|
|
Industrial production method of penehyclidine hydrochloride injection
|
CN103159770A
|
|
Crystal form of ertapenem monosodium salt
|
CN103127108A
|
|
Telmisartan amlodipine tablet, and preparation method and use thereof
|
CN102936238A
|
|
New crystal form of S-omeprazole magnesium salt and preparation method thereof
|
CN102702187A
|
|
New crystal form of penehyclidine hydrochloride and preparation method of new crystal form
|
CN102643251A
|
|
Linezolid degradation impurity and preparation method thereof
|
CN102174027A
|
|
New crystal form of linezolid and preparation method and application thereof
|
CN101926793A
|
|
Combined medicament containing telmisartan and aliskiren and preparation method thereof
|
CN101880702A
|
|
Method for producing glutathione through Candida utilis fermentation
|
CN101926978A
|
|
Medicine composition for promoting bone and bony articulation health
|
CN101965969A
|
|
Health-care food composition with anti-fatigue and immunity-improving functions and preparation method and application thereof
|
CN101961334A
|
|
Combined drug of pantoprazole and domperidone
|
CN101874802A
|
|
Slow-release medicinal composition for treating hypertension and high cholesterol
|
CN101361970A
|
|
Composition with beauty effect and health care efficacy and use thereof
|